COLLEGIUM PHARMACEUTICAL, INC (COLL) Debt-to-equity % [USD] 2015 - 2024

Historical data

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Collegium Pharmaceutical, Inc quarterly Debt-to-equity history and growth rate from 2015 to 2024.
Collegium Pharmaceutical, Inc Debt-to-equity for the quarter ending March 31, 2024 was 483 %, a 8.57% decline year-over-year.

Debt-to-equity, Quarterly (% [USD])

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	483	-45.3	-8.57%	Mar 31, 2024
Q4 2023	529	+9.75	+1.88%	Dec 31, 2023
Q3 2023	534	+81.4	+18%	Sep 30, 2023
Q2 2023	522	+159	+43.7%	Jun 30, 2023
Q1 2023	528	+253	+91.6%	Mar 31, 2023
Q4 2022	519	+301	+138%	Dec 31, 2022
Q3 2022	452	+233	+106%	Sep 30, 2022
Q2 2022	363	+124	+52.2%	Jun 30, 2022
Q1 2022	276	-1.23	-0.44%	Mar 31, 2022
Q4 2021	219	-73.4	-25.2%	Dec 31, 2021
Q3 2021	219	-81.6	-27.1%	Sep 30, 2021
Q2 2021	239	-65.2	-21.5%	Jun 30, 2021
Q1 2021	277	-11.1	-3.84%	Mar 31, 2021
Q4 2020	292	+41.2	+16.4%	Dec 31, 2020
Q3 2020	301	+58.5	+24.1%	Sep 30, 2020
Q2 2020	304	-54.6	-15.2%	Jun 30, 2020
Q1 2020	288	-187	-39.4%	Mar 31, 2020
Q4 2019	251	-336	-57.3%	Dec 31, 2019
Q3 2019	242	-275	-53.2%	Sep 30, 2019
Q2 2019	358	+23	+6.87%	Jun 30, 2019
Q1 2019	475	+296	+165%	Mar 31, 2019
Q4 2018	587	+560	+2043%	Dec 31, 2018
Q3 2018	518	+493	+2014%	Sep 30, 2018
Q2 2018	335	+310	+1226%	Jun 30, 2018
Q1 2018	179	+156	+671%	Mar 31, 2018
Q4 2017	27.4	+7.1	+35%	Dec 31, 2017
Q3 2017	24.5	+5.34	+27.9%	Sep 30, 2017
Q2 2017	25.3	+9.8	+63.3%	Jun 30, 2017
Q1 2017	23.2	+10.2	+78.2%	Mar 31, 2017
Q4 2016	20.3	-5.67	-21.8%	Dec 31, 2016
Q3 2016	19.2	-240	-92.6%	Sep 30, 2016
Q2 2016	15.5			Jun 30, 2016
Q1 2016	13			Mar 31, 2016
Q4 2015	26			Dec 31, 2015
Q3 2015	259			Sep 30, 2015

* An asterisk sign (*) next to the value indicates that the value is likely invalid.